If you want to learn more, discuss your options with a WMCHealth specialist
Collagen, hydration, and there are a lot of minor things
Due to their potential to trigger weight loss, focus on these drugs has shifted in application to obesity, with new drug products using these same ingredients gaining FDA approval for such treatment
If semaglutide isn't delivering expected results after 812 weeks, PlexusDx practitioners can transition you to tirzepatide (a dual GIP/GLP-1 agonist) or GLP-Squared, the dual-compound formulation combining both agents
We also support many clients currently on GLP-1's in optimizing their wellbeing and their results
While these side effects are typically mild to moderate, they can impact patient adherence